A NOVEL ORAL ANTIFUNGAL PLD‐118: IN VITRO ACTIVITY AGAINST CLINICAL ISOLATES OF <i>CANDIDA ALBICANS</i>

Hasenoehrl, A.; Skerlev, Mihael; Maršić, Nataša; Schoenfeld, Wolfgang

doi:10.1111/j.1439-0507.2002.tb04613.x

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A defined medium (YNG: yeast nitrogen base, glucose, pH 7.0) and an inoculum of 50-100 cfu/microtiter well (100 µl total volume) incubated for 24 h at 30 °C, was required for optimum activity of the agent due to its mode of action (i.e., active transport into yeast and inhibition of protein synthesis) (22). isoleucyl-tRNA its carrier.…”

Section: Introductionmentioning

confidence: 99%

PLD-118

Sorbera¹,

Castañer²,

Bozzo³

2002

Drugs of the Future

View full text Add to dashboard Cite

SynthesisPLD-18 can be obtained by three related ways: 1) Basic hydrolysis of cis-4-methylenecyclopentane-1,2-dicarboxylic acid diethyl ester (I) with LiOH gives the free acid (II), which by refluxing with propionic anhydride yields the cyclic anhydride (III). Rearrangement using trimethylsilyl azide in dioxane at 80 °C produces the oxazinedione (IV), which is hydrolyzed to (±)-cis-2-amino-4-methylenecyclopentane-1-carboxylic acid ethyl ester (V) by means of acetyl chloride in EtOH. Further hydrolysis of ester (V) with aqueous HCl provides the racemic amino acid (VI), which is coupled with N-(9-fluorenylmethoxycarbonyl)succinimide (VII) to afford the Fmocamino acid (VIII). Racemic (VIII) is resolved by treatment with (+)-(R)-1-phenylethylamine (IX) and crystallization of the resulting salt (X) in EtOH/methyl tert-butyl ether. Finally, acidification of salt (X) and extraction of the (1R,2S)-free acid, followed by removal of the Fmoc group with liquid ammonia, provides PLD-118 isolated as its hydrochloride salt (1). Scheme 1.2) Hydrolysis of diester (I) with KOH in water/EtOH at 55 °C gives the dicarboxylic acid (II), which is subjected to cyclization by refluxing with propionic anhydride to provide anhydride (III). Cyclic anhydride (III) is opened with allyl alcohol (XI) in diethyl ether in the presence of ()-quinine as asymmetric inducer to yield ()-1,2-cis-4-methylenecyclopentane-1,2-dicarboxylic acid monoallyl ester ()-(XII), which is then converted into the amide derivative ()-(XIII) by activation of the carboxylic acid group with isobutyl chloroformate in ethyl acetate in the presence of N-ethylmorpholine at 6 °C, followed by reaction with aqueous ammonia. Removal of the allyl group of ()-(XIII) with triphenylphosphine, tetrakis(triphenylphosphine)palladium and 2-ethylhexanoic acid sodium salt in ethyl acetate affords ()-1,2-cis-2-(aminocarbonyl)-4-methylenecyclopentane-1-carboxylic acid sodium salt ()-(XIV). Compound ()-(XIV) is subjected to a Hofmann rearrangement with KOH and KOCl in water to provide a crude aqueous solution containing PLD-118, which is finally purified by protection of the free amine group with

show abstract

Section: Introductionmentioning

confidence: 99%